Skip to main content
SpringerLink
Log in

Prostate

  • Chapter
Essentials of Anatomic Pathology

  • 5371 Accesses

Abstract

Nonneoplastic and neoplastic lesions of the prostate are presented, with emphasis on the most common disorders. The clinical, macroscopic, and microscopic features are outlined, as well as main key points used in the differential diagnosis. Among the nonneoplastic lesions of the prostate, infectious and noninfectious etiologies are included. Topics include metaplastic and inflammatory conditions, precursors, intraductal carcinoma, prostatic adenocarcinoma and its variants, and the variety of soft tissue tumors. The classic Gleason grading system is described. Practical applications of immunohistochemistry in the different entities are offered.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 449.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Suggested Reading

  • Agarwala SS. An update on pegylated IFN-alpha2b for the adjuvant treatment of melanoma. Expert Rev Anticancer Ther. 2012;12:1449–59.

    Article  CAS  PubMed  Google Scholar 

  • Alexander RE, Sung MT, Cheng L. Lymphadenectomy in urologic oncology: pathologic considerations. Urol Clin North Am. 2011;38:483–95.

    Article  PubMed  Google Scholar 

  • Arora R, Koch MO, Eble JN, et al. Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate. Cancer. 2004;100:362–2366.

    Article  Google Scholar 

  • Attard G, Parker C, Eeles RA, et al. Prostate cancer. Lancet. 2015.

    Google Scholar 

  • Biermann K, Montironi R, Lopez-Beltran A, Zhang S, Cheng L. Histopathological findings after treatment of prostate cancer using high-intensity focused ultrasound (HIFU). Prostate. 2010;70:1196–200.

    Article  PubMed  Google Scholar 

  • Bock BJ, Bostwick DG. Does prostatic ductal adenocarcinoma exist? Am J Surg Pathol. 1999;23:781–5.

    Article  CAS  PubMed  Google Scholar 

  • Bostrom PJ, Bjartell AS, Catto JW, et al. Genomic predictors of outcome in prostate cancer. Eur Urol. 2015;68:1033–44.

    Article  CAS  PubMed  Google Scholar 

  • Bostwick DG. Prospective origins of prostate carcinoma: prostatic intraepithelial neoplasia and atypical adenomatous neoplasia. Cancer. 1996;78:330–6.

    Article  CAS  PubMed  Google Scholar 

  • Bostwick DG. Evaluating prostate needle biopsy: therapeutic and prognostic importance. CA Cancer J Clin. 1997;47:297–319.

    Article  CAS  PubMed  Google Scholar 

  • Bostwick DG, Cheng L. Overdiagnosis of prostatic adenocarcinoma. Semin Urol Oncol. 1999;17:199–205.

    CAS  PubMed  Google Scholar 

  • Bostwick DG, Cheng L. Precursors of prostate cancer. Histopathology. 2012;60:4–27.

    Article  PubMed  Google Scholar 

  • Bostwick DG, Cheng L. Urologic surgical pathology. 3rd ed. Philadelphia, PA: Elsevier/Saunders; 2014.

    Google Scholar 

  • Bostwick DG, Ma J. Over-diagnosis of high grade prostatic intraepithelial neoplasia: a prospective study of 251 cases. BJU Int. 2007;100:1036–9.

    Article  PubMed  Google Scholar 

  • Bostwick DG, Meiers I. Diagnosis of prostatic carcinoma after therapy. Arch Pathol Lab Med. 2007;131:360–71.

    PubMed  Google Scholar 

  • Bostwick DG, Shan A, Qian J, et al. Independent origin of multiple foci of prostatic intraepithelial neoplasia (PIN): comparison with matched foci of prostate cancer. Cancer. 1998;83:1995–2002.

    Article  CAS  PubMed  Google Scholar 

  • Bostwick DG, Qian J, Ma J, et al. Mesonephric remnants of the prostate: incidence and histologic spectrum. Mod Pathol. 2003;16:630–5.

    Article  PubMed  Google Scholar 

  • Bostwick DG, Hossain D, Qian J, et al. Phyllodes tumor of the prostate: long-term followup study of 23 cases. J Urol. 2004;172:894–9.

    Article  PubMed  Google Scholar 

  • Cheng L, Bostwick DG. Atypical sclerosing adenosis of the prostate: a rare mimic of adenocarcinoma. Histopathology. 2010;56:627–31.

    Article  PubMed  Google Scholar 

  • Cheng L, Bergstralh E, Cheville JC, et al. Cancer volume of lymph node metastases predicts progression in prostate cancer. Am J Surg Pathol. 1998a;22:1491–500.

    Article  CAS  PubMed  Google Scholar 

  • Cheng L, Neumann RM, Blute ML, et al. Long-term follow-up of untreated stage T1a prostate cancer. J Natl Cancer Inst. 1998b;90:1105–7.

    Article  CAS  PubMed  Google Scholar 

  • Cheng L, Sebo TJ, Slezak J, et al. Predictors of survival in prostate cancer patients treated with salvage prostatectomy after radiation therapy. Cancer. 1998c;83:2164–71.

    Article  CAS  PubMed  Google Scholar 

  • Cheng L, Shan A, Cheville JC, et al. Atypical adenomatous hyperplasia of the prostate: a premalignant lesion? Cancer Res. 1998d;58:389–91.

    CAS  PubMed  Google Scholar 

  • Cheng L, Song SY, Pretlow TG, et al. Evidence of independent origin of multiple tumors from prostate cancer patients. J Natl Cancer Inst. 1998e;90:233–7.

    Article  CAS  PubMed  Google Scholar 

  • Cheng L, Bergstralh EJ, Schere BG, et al. Predictors of cancer progression in T1a prostate adenocarcinoma. Cancer. 1999a;85:1300–4.

    Article  CAS  PubMed  Google Scholar 

  • Cheng L, Bergstralh EJ, Slezak J, et al. Dedifferentiation in metastatic progression of prostate cancer. Cancer. 1999b;86:657–63.

    Article  CAS  PubMed  Google Scholar 

  • Cheng L, Bostwick DG, Guang L, et al. Allelic imbalance in the clonal evolution of prostate cancer. Cancer. 1999c;85:2017–22.

    Article  CAS  PubMed  Google Scholar 

  • Cheng L, Cheville JC, Bostwick DG. Diagnosis of prostate cancer in needle biopsies after radiation therapy. Am J Surg Pathol. 1999d;23:1173–83.

    Article  CAS  PubMed  Google Scholar 

  • Cheng L, Cheville JC, Pisansky TM, et al. Prevalence and distribution of prostatic intraepithelial neoplasia in salvage radical prostatectomy specimens after radiation therapy. Am J Surg Pathol. 1999e;23:803–8.

    Article  CAS  PubMed  Google Scholar 

  • Cheng L, Darson MF, Bergstralh EJ, et al. Correlation of margin status and extraprostatic extension with progression of prostate carcinoma. Cancer. 1999f;86:1775–82.

    Article  CAS  PubMed  Google Scholar 

  • Cheng L, Pisansky TM, Ramnani DM, et al. Extranodal extension in lymph node-positive prostate cancer. Mod Pathol. 2000a;13:113–8.

    Article  CAS  PubMed  Google Scholar 

  • Cheng L, Slezak J, Bergstralh EJ, et al. Preoperative prediction of surgical margin status in prostate cancer patients treated by radical prostatectomy. J Clin Oncol. 2000b;18:2862–8.

    CAS  PubMed  Google Scholar 

  • Cheng L, Zincke H, Blute ML, Bergstralh EJ, Scherer B, Bostwick DG. Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer. 2001a;91:66–73.

    Article  CAS  PubMed  Google Scholar 

  • Cheng L, Zincke H, Blute ML, et al. Risk of prostate cancer death in patients with lymph node metastasis. Cancer. 2001b;91:66–73.

    Article  CAS  PubMed  Google Scholar 

  • Cheng L, Jones TD, Lin H, et al. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma. J Urol. 2005a;174:2181–5.

    Article  PubMed  Google Scholar 

  • Cheng L, Jones TD, Pan CX, Barbarin A, Eble JN, Koch MO. Anatomic distribution and pathologic characterization of small-volume prostate cancer (<0.5 ml) in whole-mount prostatectomy specimens. Mod Pathol. 2005b;18:1022–6.

    Article  PubMed  Google Scholar 

  • Cheng L, Koch MO, Juliar BE, et al. The combined percentage of Gleason patterns 4 and 5 is the best predictor of cancer progression after radical prostatectomy. J Clin Oncol. 2005c;23:2911–7.

    Article  PubMed  Google Scholar 

  • Cheng L, Poulos CK, Pan CX, et al. Preoperative prediction of small volume cancer (less than 0.5-ml) in radical prostatectomy specimens. J Urol. 2005d;174:898–902.

    Article  PubMed  Google Scholar 

  • Cheng L, Davidson DD, Lin H, Koch MO. Percentage of Gleason pattern 4 and 5 predicts survival after radical prostatectomy. Cancer. 2007;110:1967–72.

    Article  PubMed  Google Scholar 

  • Cheng L, MacLennan GT, Abdul-Karim FW, et al. Eosinophilic metaplasia of the prostate: a newly described lesion distinct from other eosinophilic changes in prostatic epithelium. Anal Quant Cytol Histol. 2008;30:226–30.

    PubMed  Google Scholar 

  • Cheng L, Montironi R, Bostwick DG, Lopez-Beltran A, Berney DM. Staging of prostate cancer. Histopathology. 2012;60:87–117.

    Article  PubMed  Google Scholar 

  • Cheng L, Davidson DD, Maclennan GT, et al. Atypical adenomatous hyperplasia of prostate lacks TMPRSS2-ERG gene fusion. Am J Surg Pathol. 2013;37:1550–4.

    Article  PubMed  Google Scholar 

  • Edge SB, American Joint Committee on Cancer. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.

    Google Scholar 

  • Eichelberger LE, Cheng L. Does pT2b prostate carcinoma exist? Critical appraisal of the 2002 TNM classification of prostate carcinoma. Cancer. 2004;100:2573–6.

    Article  PubMed  Google Scholar 

  • Eichelberger LE, Koch MO, Eble JN, Ulbright TM, Juliar BE, Cheng L. Maximum tumor diameter is an independent predictor of prostate-specific antigen recurrence in prostate cancer. Mod Pathol. 2005;18:886–90.

    Article  PubMed  Google Scholar 

  • Emerson RE, Koch MO, Daggy JK, Cheng L. Closest distance between tumor and resection margin in radical prostatectomy specimens: lack of prognostic significance. Am J Surg Pathol. 2005;29:225–9.

    Article  PubMed  Google Scholar 

  • Epstein JI, Allsbrook Jr WC, Amin MB, Egevad LL. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol. 2005;29:1228–42.

    Article  PubMed  Google Scholar 

  • Epstein JI, Amin MB, Beltran H, et al. Proposed morphologic classification of prostate cancer with neuroendocrine differentiation. Am J Surg Pathol. 2014a;38:756–67.

    Article  PubMed Central  PubMed  Google Scholar 

  • Epstein JI, Egevad L, Amin MB, et al. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System. Am J Surg Pathol. 2015.

    Google Scholar 

  • Epstein JI, Egevad L, Humphrey PA, Montironi R. Members of the IIiDUPG. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol. 2014c;38:e6–19.

    Article  PubMed  Google Scholar 

  • Fisher KW, Montironi R, Lopez Beltran A, et al. Molecular foundations for personalized therapy in prostate cancer. Curr Drug Targets. 2015;16:103–14.

    Article  CAS  PubMed  Google Scholar 

  • Galosi AB, Mazzucchelli R, Scarpelli M, et al. Solitary fibrous tumour of the prostate identified on needle biopsy. Eur Urol. 2009;56:564–7.

    Article  PubMed  Google Scholar 

  • Halat S, Eble JN, Grignon DJ, et al. Ectopic prostatic tissue: histogenesis and histopathological characteristics. Histopathology. 2011;58:750–8.

    Article  PubMed  Google Scholar 

  • Hattab EM, Koch MO, Eble JN, Lin H, Cheng L. Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma. J Urol. 2006;175:1695–9.

    Article  PubMed  Google Scholar 

  • Hong H, Koch MO, Foster RS, et al. Anatomic distribution of periprostatic adipose tissue: a mapping study of 100 radical prostatectomy specimens. Cancer. 2003;97:1639–43.

    Article  PubMed  Google Scholar 

  • Hossain D, Meiers I, Qian J, MacLennan GT, Bostwick DG. Prostatic stromal hyperplasia with atypia: follow-up study of 18 cases. Arch Pathol Lab Med. 2008;132:1729–33.

    PubMed  Google Scholar 

  • Iczkowski KA, Egevad L, Ma J, et al. Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists. Ann Diagn Pathol. 2014;18:333–42.

    Article  PubMed  Google Scholar 

  • Lopez-Beltran A, Cheng L, Prieto R, Bianca A, Montironi R. Lymphoepithelioma-like carcinoma of the prostate. Hum Pathol. 2009;40:982–7.

    Article  PubMed  Google Scholar 

  • Marks RA, Koch MO, Lopez-Beltran A, Montironi R, Juliar BE, Cheng L. Relationship between the extent of surgical margin positivity and prostate-specific antigen recurrence in radical prostatectomy specimens. Hum Pathol. 2007a;38:1207–11.

    Article  CAS  PubMed  Google Scholar 

  • Marks RA, Lin H, Koch MO, Cheng L. Positive-block ratio in radical prostatectomy specimens is an independent predictor of prostate-specific antigen recurrence. Am J Surg Pathol. 2007b;31:311–8.

    Article  Google Scholar 

  • Mazzucchelli R, Lopez-Beltran A, Cheng L, et al. Rare and unusual histological variants of prostatic carcinoma: clinical significance. BJU Int. 2009a;102:1369–74.

    Google Scholar 

  • Mazzucchelli R, Morichetti D, Lopez-Beltran A, et al. Neuroendocrine tumours of the urinary system and male genital organs: clinical significance. BJU Int. 2009b;103:1464–70.

    Article  PubMed  Google Scholar 

  • Mazzucchelli R, Lopez-Beltran A, Galosi AB, et al. Prostate changes related to therapy: with special reference to hormone therapy. Future Oncol. 2014;10:1873–86.

    Article  CAS  PubMed  Google Scholar 

  • Moch H, Humphrey PA, Ulbright TM, Reuter VE. Classification of tumours of the urinary system and male genital organs. Lyon: International Agency for Research on Cancer (IARC) Press; 2016.

    Google Scholar 

  • Montironi R, Scattoni V, Mazzucchelli R, et al. Atypical foci suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as “atypical small acinar proliferation suspicious for but not diagnostic of malignancy”). Eur Urol. 2006;50:666–74.

    Article  CAS  PubMed  Google Scholar 

  • Montironi R, Cheng L, Scarpelli M, et al. Pathological reflection on European Urology: extended, saturation, and systematic prostate biopsies. Eur Urol. 2008;53:1111–4.

    Article  PubMed  Google Scholar 

  • Montironi R, Cheng L, Lopez-Beltran A, et al. Stage pT0 in radical prostatectomy with no residual carcinoma and with a previous positive biopsy conveys a wrong message to clinicians and patients: why is cancer not present in the radical prostatectomy specimen? Eur Urol. 2009a;56:272–4.

    Article  PubMed  Google Scholar 

  • Montironi R, Cheng L, Lopez-Beltran A, et al. Joint appraisal of the radical prostatectomy specimens by the urologist and uropathologist. Eur Urol. 2009b;56:951–5.

    Article  PubMed  Google Scholar 

  • Montironi R, Cheng L, Mazzucchelli R, et al. Critical pathological evaluation of the prostate from cystoprostatectomies for bladder cancer: insights from a complete sampling with the whole mount technique. Eur Urol. 2009c;55:1305–9.

    Article  PubMed  Google Scholar 

  • Montironi R, Cheng L, Lopez-Beltran A, et al. Original Gleason System versus 2005 ISUP Modified Gleason System. Eur Urol. 2010;58:369–73.

    Article  PubMed  Google Scholar 

  • Montironi R, Scarpelli M, Cheng L, Lopez-Beltran A, Zhou M, Montorsi F. Do not misinterpret intraductal carcinoma of the prostate as high-grade prostatic intraepithelial neoplasia! Eur Urol. 2012a;62:518–22.

    Article  PubMed  Google Scholar 

  • Montironi R, Scarpelli M, Mazzucchelli R, Cheng L, Lopez-Beltran A, Montorsi F. Extent of cancer of less than 50% in any prostate needle biopsy core: how many millimeters are there? Eur Urol. 2012b;61:751–6.

    Article  PubMed  Google Scholar 

  • Montironi R, Lopez-Beltran A, Cheng L, Montorsi F, Scarpelli M. Central prostate pathology review: should it be mandatory? Eur Urol. 2013;64:199–201.

    Article  PubMed  Google Scholar 

  • Montironi R, Lopez-Beltran A, Cheng L, Galosi AB, Montorsi F, Scarpelli M. Seminal vesicle intraepithelial neoplasia versus basal cell hyperplasia in a seminal vesicle. Eur Urol. 2014;66:623–7.

    Article  PubMed  Google Scholar 

  • Montironi R, Cheng L, Lopez-Beltran A, Scarpelli M, Montorsi F. A better understating of the morphological features and molecular characteristics of intraductal carcinoma helps clinicians further explain prostate cancer aggressiveness. Eur Urol. 2015;67:504–7.

    Article  PubMed  Google Scholar 

  • Netto GJ, Cheng L. Emerging critical role of molecular testing in diagnostic genitourinary pathology. Arch Pathol Lab Med. 2012;136:372–90.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Ng JC, Koch MO, Daggy JK, Cheng L. Perineural invasion in radical prostatectomy specimens: lack of prognostic significance. J Urol. 2004;172:2249–51.

    Article  PubMed  Google Scholar 

  • Poulos CK, Daggy JK, Cheng L. Prostate needle biopsies: multiple variables are predictive of final tumor volume in radical prostatectomy specimens. Cancer. 2004a;101:527–32.

    Article  PubMed  Google Scholar 

  • Poulos CK, Koch MO, Eble JN, Daggy JK, Cheng L. Bladder neck invasion is an independent predictor of prostate-specific antigen recurrence. Cancer. 2004b;101:1563–8.

    Article  PubMed  Google Scholar 

  • Poulos CK, Daggy JK, Cheng L. Preoperative prediction of Gleason grade in radical prostatectomy specimens: the influence of different Gleason grades from multiple positive biopsy sites. Mod Pathol. 2005;18:228–34.

    Article  PubMed  Google Scholar 

  • Santoni M, Piva F, Scarpelli M, et al. The origin of prostate metastases: emerging insights. Cancer Metastasis Rev. 2015a;34:765–73.

    Article  CAS  PubMed  Google Scholar 

  • Santoni M, Scarpelli M, Mazzucchelli R, et al. Current histopathologic and molecular characterisations of prostate cancer: towards individualised prognosis and therapies. Eur Urol. 2015.

    Google Scholar 

  • Seipel AH, Delahunt B, Samaratunga H, et al. Diagnostic criteria for ductal adenocarcinoma of the prostate: interobserver variability among 20 expert uropathologists. Histopathology. 2014;65:216–27.

    Article  PubMed  Google Scholar 

  • Shah RB, Li J, Cheng L, et al. Diagnosis of Gleason pattern 5 prostate adenocarcinoma on core needle biopsy: an interobserver reproducibility study among urologic pathologists. Am J Surg Pathol. 2015;39:1242–9.

    Article  PubMed  Google Scholar 

  • Simper NB, Jones CL, MacLennan GT, et al. Basal cell carcinoma of the prostate is an aggressive tumor with frequent loss of PTEN expression and overexpression of EGFR. Hum Pathol. 2015;46:805–12.

    Article  CAS  PubMed  Google Scholar 

  • Srigley JR, Amin MB, Epstein JI, et al. Updated protocol for the examination of specimens from patients with carcinomas of the prostate gland. Arch Pathol Lab Med. 2006;130:936–46.

    PubMed  Google Scholar 

  • Sung MT, Cheng L. Contemporary approaches for processing and handling of radical prostatectomy specimens. Histol Histopathol. 2010;25:259–65.

    PubMed  Google Scholar 

  • Sung MT, Eble JN, Cheng L. Invasion of fat justifies assignment of stage pT3a in prostatic adenocarcinoma. Pathology. 2006;38:309–11.

    Article  PubMed  Google Scholar 

  • Sung MT, Lin H, Koch MO, Davidson DD, Cheng L. Radial distance of extraprostatic extension measured by ocular micrometer is an independent predictor of prostate-specific antigen recurrence: a new proposal for the substaging of pT3a prostate cancer. Am J Surg Pathol. 2007;31:311–8.

    Article  PubMed  Google Scholar 

  • Van der Kwast TH, Evans A, Lockwood G, et al. Variability in diagnostic opinion among pathologists for single small atypical foci in prostate biopsies. Am J Surg Pathol. 2010;34:169–77.

    Article  PubMed  Google Scholar 

  • Wang L, Davidson DD, Montironi R, et al. Small cell carcinoma of the prostate: molecular basis and clinical implications. Histol Histopathol. 2015;30:413–24.

    CAS  PubMed  Google Scholar 

  • Wilkerson ML, Lin F, Liu H, Cheng L. The application of immunohistochemical biomarkers in urologic surgical pathology. Arch Pathol Lab Med. 2014;138:1643–65.

    Article  PubMed  Google Scholar 

  • Williamson SR, Cheng L. Prostate cancer: effects of tertiary Gleason pattern 5 on oncological outcome. Nat Rev Urol. 2015;12:188–9.

    Article  PubMed  Google Scholar 

  • Williamson SR, Zhang S, Yao JL, et al. ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin. Mod Pathol. 2011;24:1120–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Zhang C, Montironi R, MacLennan GT, et al. Is atypical adenomatous hyperplasia of the prostate a precursor lesion? Prostate. 2011;71:1746–51.

    Article  CAS  PubMed  Google Scholar 

  • Zhou M, Li J, Cheng L, et al. Diagnosis of “Poorly Formed Glands” Gleason Pattern 4 Prostatic Adenocarcinoma on Needle Biopsy: An Interobserver Reproducibility Study Among Urologic Pathologists With Recommendations. Am J Surg Pathol. 2015;39:1331–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Granger Diagnostics, North Chesterfield, VA, USA

    David G. Bostwick MD

  2. Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA

    Liang Cheng MD

Authors
  1. David G. Bostwick MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Liang Cheng MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Liang Cheng MD .

Editor information

Editors and Affiliations

  1. Indiana University School of Medicine, Indianapolis, Indiana, USA

    Liang Cheng

  2. Granger Diagnostics, A Division of Granger Genetics, North Chesterfield, Virginia, USA

    David G. Bostwick

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Bostwick, D.G., Cheng, L. (2016). Prostate. In: Cheng, L., Bostwick, D. (eds) Essentials of Anatomic Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-23380-2_38

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-23380-2_38

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-23379-6

  • Online ISBN: 978-3-319-23380-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation